|
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 19.46 USD | -1.07% |
|
0.00% | +11.06% |
| May. 14 | Transcript : Kiniksa Pharmaceuticals, Ltd. Presents at Bank of America Health Care Conference 2024, May-14-2024 10:40 AM | |
| Apr. 23 | Kiniksa Pharmaceuticals Q1 Loss Widens, Revenue Rises | MT |
Kiniksa Pharmaceuticals, Ltd. reported earnings results for the first quarter ended March 31, 2023. For the first quarter, the company reported revenue was USD 48.35 million compared to USD 32.19 million a year ago. Net loss was USD 12.27 million compared to USD 25.21 million a year ago.
Basic loss per share from continuing operations was USD 0.18 compared to USD 0.36 a year ago.
| 1st Jan change | Capi. | |
|---|---|---|
| +11.06% | 1.4B | |
| +8.33% | 115B | |
| +12.99% | 107B | |
| -13.62% | 22.31B | |
| -3.99% | 21.6B | |
| -5.79% | 18.23B | |
| -39.93% | 17.62B | |
| +7.46% | 14.26B | |
| +33.48% | 12.37B | |
| -28.25% | 8.28B |
KINIKSA PHARMACEUTICALS, LTD. 